CRGT (Cortigent) שווי עסקי להכנסות

Cortigent, Inc. develops neural interfaces to restore motor functions and vision for patients. The EV/Sales ratio confirms the market valuation of the business, where the level represents the current value. The asset demonstrates high macro-resilience and independence from GDP. However, the R&D stage and lack of revenue, coupled with significant equipment costs, temporarily block profit scaling.
פילוחי מדדים פיננסיים ומדדי שוק עבור Cortigent Inc (CRGT)

This indicator determines the market value of the business accounting for net debt relative to sales volume, allowing for an assessment of the premium paid for generated revenue. By analyzing the EV/Sales ratio, an investor can see the impact of the debt load on the capitalization of Cortigent, Inc. (CRGT), where a high valuation is justified by the uniqueness of its neurotechnologies and the protection of its patent portfolio from competition.